Aaron Robert Roseth Acquires 13,500 Shares of Global Medical REIT (NYSE:XRN) Stock

Global Medical REIT Inc. (NYSE:XRN) COO Aaron Robert Roseth acquired 13,500 shares of the firm’s stock in a transaction that occurred on Wednesday, August 12th. The shares were purchased at an average price of $36.73 per share, with a total value of $495,855.00. Following the completion of the acquisition, the chief operating officer owned 13,500 shares of the company’s stock, valued at $495,855. This represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Global Medical REIT Stock Up 0.7%

XRN traded up $0.25 during trading hours on Thursday, hitting $36.52. 100,235 shares of the company’s stock were exchanged, compared to its average volume of 89,274. The stock has a market cap of $483.50 million, a price-to-earnings ratio of 9.82 and a beta of 1.09. Global Medical REIT Inc. has a 1-year low of $29.05 and a 1-year high of $39.93. The stock’s 50-day moving average is $36.59 and its two-hundred day moving average is $35.80. The company has a quick ratio of 0.68, a current ratio of 0.68 and a debt-to-equity ratio of 1.68.

Global Medical REIT (NYSE:XRN) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $4.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.83 by $3.95. Global Medical REIT had a net margin of 36.82% and a return on equity of 13.74%. The firm had revenue of $39.75 million for the quarter. Sell-side analysts predict that Global Medical REIT Inc. will post 3.06 earnings per share for the current fiscal year.

Key Headlines Impacting Global Medical REIT

Here are the key news stories impacting Global Medical REIT this week:

• Positive Sentiment: Director Charles Fitzgerald purchased 14,000 shares for approximately $500,920 at an average price of $35.78, increasing his direct ownership by 11.21%. This followed his purchase of another 27,600 shares, worth about $991,944, on August 10. SEC insider purchase filing
• Positive Sentiment: CEO Mark Okey Decker Jr. bought 8,000 shares for $287,040 on August 10 and an additional 550 shares for $19,800 on August 11. The purchases increased his holdings by 13.38% and 0.81%, respectively, signaling management confidence in the company’s valuation and outlook. CEO insider buying report
• Positive Sentiment: Global Medical REIT reported quarterly earnings per share of $4.78, exceeding the $0.83 consensus estimate by $3.95, with revenue of $39.75 million. The company posted a 36.82% net margin and 13.74% return on equity, while analysts expect full-year EPS of $3.06.
• Positive Sentiment: Some analysts remain constructive: Citizens JMP raised its price target to $42 from $40 and maintained an outperform rating. The average analyst price target is $40.25, above the recent trading level.
• Neutral Sentiment: Institutional ownership remains substantial at 57.52%. Invesco increased its position, and several other investment firms recently initiated or expanded holdings, providing some support from professional investors.
• Negative Sentiment: Analyst sentiment is mixed, with an overall “Hold” rating. Compass Point cut its price target to $38 from $50, Wall Street Zen downgraded the stock to “Sell,” and Raymond James initiated coverage at “Market Perform.”
• Negative Sentiment: The REIT carries meaningful leverage, with a debt-to-equity ratio of 1.68 and current and quick ratios of 0.68, factors that could limit financial flexibility if interest rates or property-market conditions worsen.

Hedge Funds Weigh In On Global Medical REIT

A number of institutional investors have recently bought and sold shares of XRN. Caitong International Asset Management Co. Ltd lifted its position in shares of Global Medical REIT by 1,001.4% in the third quarter. Caitong International Asset Management Co. Ltd now owns 793 shares of the company’s stock valued at $27,000 after buying an additional 721 shares during the last quarter. Fifth Third Bancorp raised its stake in Global Medical REIT by 35.3% in the 4th quarter. Fifth Third Bancorp now owns 1,417 shares of the company’s stock valued at $48,000 after acquiring an additional 370 shares during the period. Virtus Advisers LLC raised its stake in Global Medical REIT by 46.5% in the 4th quarter. Virtus Advisers LLC now owns 2,418 shares of the company’s stock valued at $82,000 after acquiring an additional 768 shares during the period. Eurizon Capital SGR S.p.A. acquired a new stake in Global Medical REIT during the 4th quarter valued at $92,000. Finally, SG Americas Securities LLC acquired a new stake in Global Medical REIT during the 4th quarter valued at $121,000. Institutional investors and hedge funds own 57.52% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have weighed in on XRN. Citizens Jmp boosted their price target on Global Medical REIT from $40.00 to $42.00 and gave the stock a “market outperform” rating in a research report on Tuesday, May 26th. Wall Street Zen cut shares of Global Medical REIT from a “hold” rating to a “sell” rating in a research note on Saturday, May 9th. Zacks Research upgraded shares of Global Medical REIT to a “hold” rating in a report on Wednesday, July 22nd. BMO Capital Markets boosted their target price on shares of Global Medical REIT from $39.00 to $40.00 and gave the stock a “market perform” rating in a report on Monday, July 13th. Finally, Weiss Ratings lowered shares of Global Medical REIT from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, July 30th. Two analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Global Medical REIT has a consensus rating of “Hold” and a consensus target price of $40.25.

About Global Medical REIT

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.